Cargando…
Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec
Gene therapies have potential to improve outcomes of severe diseases after only a single administration. Novel therapies are continually being developed using knowledge gained from prior successes, a concept known as scientific spillover. Gene therapy advancement requires extensive development at ea...
Autores principales: | Asher, Damon, Dai, Daisy, Klimchak, Alexa C., Sedita, Lauren E., Gooch, Katherine L., Rodino-Klapac, Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477757/ https://www.ncbi.nlm.nih.gov/pubmed/37674905 http://dx.doi.org/10.1016/j.omtm.2023.08.002 |
Ejemplares similares
-
Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States
por: Klimchak, Alexa C., et al.
Publicado: (2023) -
Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
por: Mendell, Jerry R., et al.
Publicado: (2023) -
Commercial health plans use of patient subgroup restrictions: An analysis of orphan and US Food and Drug Administration–expedited programs
por: Jenkins, Nola B, et al.
Publicado: (2023) -
Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005) -
MicroRNA Based Treatment of Cardiomyopathy: Not all Dystrophies are Created Equal
por: Rodino‐Klapac, Louise R.
Publicado: (2013)